Skip to main content
Erschienen in: Virchows Archiv 4/2018

05.12.2017 | Review and Perspectives

Eighth Edition of the UICC Classification of Malignant Tumours: an overview of the changes in the pathological TNM classification criteria—What has changed and why?

verfasst von: Luca Bertero, Federica Massa, Jasna Metovic, Roberto Zanetti, Isabella Castellano, Umberto Ricardi, Mauro Papotti, Paola Cassoni

Erschienen in: Virchows Archiv | Ausgabe 4/2018

Einloggen, um Zugang zu erhalten

Abstract

The TNM classification of malignant tumours is a mainstay tool in clinical practice and research for prognostic assessment of patients, treatment allocation and trial enrolment, as well as for epidemiological studies and data collection by cancer registries worldwide. Pathological TNM (pTNM) represents the pathological classification of a tumor, assigned after surgical resection or adequate sampling by biopsy, and periodical updates to the relative classification criteria are necessary to preserve its clinical relevance by integrating newly reported data. A structured approach has been put in place to fulfil this need and, based upon this process, the Eighth Edition of Union for International Cancer Control (UICC) TNM Classification of Malignant Tumours has been published, introducing many significant changes, including novel classification criteria for specific tumour types. In this review, we aim to describe the major changes introduced in the pTNM classification criteria and to summarize the evidence supporting these changes.
Literatur
2.
Zurück zum Zitat Amin MB, Edge SB, Greene FL, Byrd DR, Brookland RK, Washington MK, Gershenwald JE, Compton CC, Hess KR, Sullivan DC (2016) AJCC cancer staging manual. Springer International Publishing Amin MB, Edge SB, Greene FL, Byrd DR, Brookland RK, Washington MK, Gershenwald JE, Compton CC, Hess KR, Sullivan DC (2016) AJCC cancer staging manual. Springer International Publishing
3.
Zurück zum Zitat Brierley J, Gospodarowicz MK, Wittekind C (2017) TNM classification of malignant tumours. Wiley, Chichester Brierley J, Gospodarowicz MK, Wittekind C (2017) TNM classification of malignant tumours. Wiley, Chichester
4.
Zurück zum Zitat Sobin LH, Gospodarowicz MK, Wittekind C, International Union against Cancer (2010) TNM classification of malignant tumours. Wiley-Blackwell, Chichester Sobin LH, Gospodarowicz MK, Wittekind C, International Union against Cancer (2010) TNM classification of malignant tumours. Wiley-Blackwell, Chichester
5.
Zurück zum Zitat International Consortium for Outcome Research in H, Neck C, Ebrahimi A, Gil Z, Amit M, Yen TC, Liao CT, Chaturvedi P, Agarwal JP, Kowalski LP, Kreppel M, Cernea CR, Brandao J, Bachar G, Bolzoni Villaret A, Fliss D, Fridman E, Robbins KT, Shah JP, Patel SG, Clark JR (2014) Primary tumor staging for oral cancer and a proposed modification incorporating depth of invasion: an international multicenter retrospective study. JAMA Otolaryngol Head Neck Surg 140(12):1138–1148. https://doi.org/10.1001/jamaoto.2014.1548 CrossRef International Consortium for Outcome Research in H, Neck C, Ebrahimi A, Gil Z, Amit M, Yen TC, Liao CT, Chaturvedi P, Agarwal JP, Kowalski LP, Kreppel M, Cernea CR, Brandao J, Bachar G, Bolzoni Villaret A, Fliss D, Fridman E, Robbins KT, Shah JP, Patel SG, Clark JR (2014) Primary tumor staging for oral cancer and a proposed modification incorporating depth of invasion: an international multicenter retrospective study. JAMA Otolaryngol Head Neck Surg 140(12):1138–1148. https://​doi.​org/​10.​1001/​jamaoto.​2014.​1548 CrossRef
7.
Zurück zum Zitat Huang SH, Xu W, Waldron J, Siu L, Shen X, Tong L, Ringash J, Bayley A, Kim J, Hope A, Cho J, Giuliani M, Hansen A, Irish J, Gilbert R, Gullane P, Perez-Ordonez B, Weinreb I, Liu FF, O'Sullivan B (2015) Refining American Joint Committee on Cancer/Union for International Cancer Control TNM stage and prognostic groups for human papillomavirus-related oropharyngeal carcinomas. J Clin Oncol 33(8):836–845. https://doi.org/10.1200/JCO.2014.58.6412 CrossRefPubMed Huang SH, Xu W, Waldron J, Siu L, Shen X, Tong L, Ringash J, Bayley A, Kim J, Hope A, Cho J, Giuliani M, Hansen A, Irish J, Gilbert R, Gullane P, Perez-Ordonez B, Weinreb I, Liu FF, O'Sullivan B (2015) Refining American Joint Committee on Cancer/Union for International Cancer Control TNM stage and prognostic groups for human papillomavirus-related oropharyngeal carcinomas. J Clin Oncol 33(8):836–845. https://​doi.​org/​10.​1200/​JCO.​2014.​58.​6412 CrossRefPubMed
8.
Zurück zum Zitat Dahlstrom KR, Calzada G, Hanby JD, Garden AS, Glisson BS, Li G, Roberts DB, Weber RS, Sturgis EM (2013) An evolution in demographics, treatment, and outcomes of oropharyngeal cancer at a major cancer center: a staging system in need of repair. Cancer 119(1):81–89. https://doi.org/10.1002/cncr.27727 CrossRefPubMed Dahlstrom KR, Calzada G, Hanby JD, Garden AS, Glisson BS, Li G, Roberts DB, Weber RS, Sturgis EM (2013) An evolution in demographics, treatment, and outcomes of oropharyngeal cancer at a major cancer center: a staging system in need of repair. Cancer 119(1):81–89. https://​doi.​org/​10.​1002/​cncr.​27727 CrossRefPubMed
9.
Zurück zum Zitat Haughey BH, Sinha P, Kallogjeri D, Goldberg RL, Lewis JS Jr, Piccirillo JF, Jackson RS, Moore EJ, Brandwein-Gensler M, Magnuson SJ, Carroll WR, Jones TM, Wilkie MD, Lau A, Upile NS, Sheard J, Lancaster J, Tandon S, Robinson M, Husband D, Ganly I, Shah JP, Brizel DM, O'Sullivan B, Ridge JA, Lydiatt WM (2016) Pathology-based staging for HPV-positive squamous carcinoma of the oropharynx. Oral Oncol 62:11–19. https://doi.org/10.1016/j.oraloncology.2016.09.004 CrossRefPubMedPubMedCentral Haughey BH, Sinha P, Kallogjeri D, Goldberg RL, Lewis JS Jr, Piccirillo JF, Jackson RS, Moore EJ, Brandwein-Gensler M, Magnuson SJ, Carroll WR, Jones TM, Wilkie MD, Lau A, Upile NS, Sheard J, Lancaster J, Tandon S, Robinson M, Husband D, Ganly I, Shah JP, Brizel DM, O'Sullivan B, Ridge JA, Lydiatt WM (2016) Pathology-based staging for HPV-positive squamous carcinoma of the oropharynx. Oral Oncol 62:11–19. https://​doi.​org/​10.​1016/​j.​oraloncology.​2016.​09.​004 CrossRefPubMedPubMedCentral
12.
Zurück zum Zitat Pan JJ, Ng WT, Zong JF, Chan LL, O'Sullivan B, Lin SJ, Sze HC, Chen YB, Choi HC, Guo QJ, Kan WK, Xiao YP, Wei X, Le QT, Glastonbury CM, Colevas AD, Weber RS, Shah JP, Lee AW (2016) Proposal for the 8th edition of the AJCC/UICC staging system for nasopharyngeal cancer in the era of intensity-modulated radiotherapy. Cancer 122(4):546–558. https://doi.org/10.1002/cncr.29795 CrossRefPubMed Pan JJ, Ng WT, Zong JF, Chan LL, O'Sullivan B, Lin SJ, Sze HC, Chen YB, Choi HC, Guo QJ, Kan WK, Xiao YP, Wei X, Le QT, Glastonbury CM, Colevas AD, Weber RS, Shah JP, Lee AW (2016) Proposal for the 8th edition of the AJCC/UICC staging system for nasopharyngeal cancer in the era of intensity-modulated radiotherapy. Cancer 122(4):546–558. https://​doi.​org/​10.​1002/​cncr.​29795 CrossRefPubMed
19.
Zurück zum Zitat Davison JM, Choudry HA, Pingpank JF, Ahrendt SA, Holtzman MP, Zureikat AH, Zeh HJ, Ramalingam L, Zhu B, Nikiforova M, Bartlett DL, Pai RK (2014) Clinicopathologic and molecular analysis of disseminated appendiceal mucinous neoplasms: identification of factors predicting survival and proposed criteria for a three-tiered assessment of tumor grade. Mod Pathol 27(11):1521–1539. https://doi.org/10.1038/modpathol.2014.37 CrossRefPubMed Davison JM, Choudry HA, Pingpank JF, Ahrendt SA, Holtzman MP, Zureikat AH, Zeh HJ, Ramalingam L, Zhu B, Nikiforova M, Bartlett DL, Pai RK (2014) Clinicopathologic and molecular analysis of disseminated appendiceal mucinous neoplasms: identification of factors predicting survival and proposed criteria for a three-tiered assessment of tumor grade. Mod Pathol 27(11):1521–1539. https://​doi.​org/​10.​1038/​modpathol.​2014.​37 CrossRefPubMed
21.
Zurück zum Zitat Franko J, Shi Q, Meyers JP, Maughan TS, Adams RA, Seymour MT, Saltz L, Punt CJ, Koopman M, Tournigand C, Tebbutt NC, Diaz-Rubio E, Souglakos J, Falcone A, Chibaudel B, Heinemann V, Moen J, De Gramont A, Sargent DJ, Grothey A, Analysis, Research in Cancers of the Digestive System G (2016) Prognosis of patients with peritoneal metastatic colorectal cancer given systemic therapy: an analysis of individual patient data from prospective randomised trials from the analysis and research in cancers of the digestive system (ARCAD) database. Lancet Oncol. 17(12):1709–1719. https://doi.org/10.1016/S1470-2045(16)30500-9 CrossRefPubMed Franko J, Shi Q, Meyers JP, Maughan TS, Adams RA, Seymour MT, Saltz L, Punt CJ, Koopman M, Tournigand C, Tebbutt NC, Diaz-Rubio E, Souglakos J, Falcone A, Chibaudel B, Heinemann V, Moen J, De Gramont A, Sargent DJ, Grothey A, Analysis, Research in Cancers of the Digestive System G (2016) Prognosis of patients with peritoneal metastatic colorectal cancer given systemic therapy: an analysis of individual patient data from prospective randomised trials from the analysis and research in cancers of the digestive system (ARCAD) database. Lancet Oncol. 17(12):1709–1719. https://​doi.​org/​10.​1016/​S1470-2045(16)30500-9 CrossRefPubMed
22.
Zurück zum Zitat Franko J, Shi Q, Goldman CD, Pockaj BA, Nelson GD, Goldberg RM, Pitot HC, Grothey A, Alberts SR, Sargent DJ (2012) Treatment of colorectal peritoneal carcinomatosis with systemic chemotherapy: a pooled analysis of north central cancer treatment group phase III trials N9741 and N9841. J Clin Oncol 30(3):263–267. https://doi.org/10.1200/JCO.2011.37.1039 CrossRefPubMed Franko J, Shi Q, Goldman CD, Pockaj BA, Nelson GD, Goldberg RM, Pitot HC, Grothey A, Alberts SR, Sargent DJ (2012) Treatment of colorectal peritoneal carcinomatosis with systemic chemotherapy: a pooled analysis of north central cancer treatment group phase III trials N9741 and N9841. J Clin Oncol 30(3):263–267. https://​doi.​org/​10.​1200/​JCO.​2011.​37.​1039 CrossRefPubMed
24.
Zurück zum Zitat Goh BK, Teo JY, Chan CY, Lee SY, Jeyaraj P, Cheow PC, Chow PK, Ooi LL, Chung AY (2016) Importance of tumor size as a prognostic factor after partial liver resection for solitary hepatocellular carcinoma: implications on the current AJCC staging system. J Surg Oncol 113(1):89–93. https://doi.org/10.1002/jso.24099 CrossRefPubMed Goh BK, Teo JY, Chan CY, Lee SY, Jeyaraj P, Cheow PC, Chow PK, Ooi LL, Chung AY (2016) Importance of tumor size as a prognostic factor after partial liver resection for solitary hepatocellular carcinoma: implications on the current AJCC staging system. J Surg Oncol 113(1):89–93. https://​doi.​org/​10.​1002/​jso.​24099 CrossRefPubMed
25.
Zurück zum Zitat Shindoh J, Andreou A, Aloia TA, Zimmitti G, Lauwers GY, Laurent A, Nagorney DM, Belghiti J, Cherqui D, Poon RT, Kokudo N, Vauthey JN (2013) Microvascular invasion does not predict long-term survival in hepatocellular carcinoma up to 2 cm: reappraisal of the staging system for solitary tumors. Ann Surg Oncol 20(4):1223–1229. https://doi.org/10.1245/s10434-012-2739-y CrossRefPubMed Shindoh J, Andreou A, Aloia TA, Zimmitti G, Lauwers GY, Laurent A, Nagorney DM, Belghiti J, Cherqui D, Poon RT, Kokudo N, Vauthey JN (2013) Microvascular invasion does not predict long-term survival in hepatocellular carcinoma up to 2 cm: reappraisal of the staging system for solitary tumors. Ann Surg Oncol 20(4):1223–1229. https://​doi.​org/​10.​1245/​s10434-012-2739-y CrossRefPubMed
26.
Zurück zum Zitat Arii S, Yamaoka Y, Futagawa S, Inoue K, Kobayashi K, Kojiro M, Makuuchi M, Nakamura Y, Okita K, Yamada R (2000) Results of surgical and nonsurgical treatment for small-sized hepatocellular carcinomas: a retrospective and nationwide survey in Japan. The Liver Cancer Study Group of Japan Hepatology 32(6):1224–1229. https://doi.org/10.1053/jhep.2000.20456 Arii S, Yamaoka Y, Futagawa S, Inoue K, Kobayashi K, Kojiro M, Makuuchi M, Nakamura Y, Okita K, Yamada R (2000) Results of surgical and nonsurgical treatment for small-sized hepatocellular carcinomas: a retrospective and nationwide survey in Japan. The Liver Cancer Study Group of Japan Hepatology 32(6):1224–1229. https://​doi.​org/​10.​1053/​jhep.​2000.​20456
31.
Zurück zum Zitat Ali SM, Clark CJ, Mounajjed T, Wu TT, Harmsen WS, Reid-Lombardo KM, Truty MJ, Kendrick ML, Farnell MB, Nagorney DM, Que FG (2015) Model to predict survival after surgical resection of intrahepatic cholangiocarcinoma: the Mayo Clinic experience. HPB (Oxford) 17(3):244–250. https://doi.org/10.1111/hpb.12333 CrossRef Ali SM, Clark CJ, Mounajjed T, Wu TT, Harmsen WS, Reid-Lombardo KM, Truty MJ, Kendrick ML, Farnell MB, Nagorney DM, Que FG (2015) Model to predict survival after surgical resection of intrahepatic cholangiocarcinoma: the Mayo Clinic experience. HPB (Oxford) 17(3):244–250. https://​doi.​org/​10.​1111/​hpb.​12333 CrossRef
32.
Zurück zum Zitat Kim Y, Moris DP, Zhang XF, Bagante F, Spolverato G, Schmidt C, Dilhoff M, Pawlik TM (2017) Evaluation of the 8th edition American joint commission on cancer (AJCC) staging system for patients with intrahepatic cholangiocarcinoma: a surveillance, epidemiology, and end results (SEER) analysis. J Surg Oncol 116(6):643–650. https://doi.org/10.1002/jso.24720 CrossRefPubMed Kim Y, Moris DP, Zhang XF, Bagante F, Spolverato G, Schmidt C, Dilhoff M, Pawlik TM (2017) Evaluation of the 8th edition American joint commission on cancer (AJCC) staging system for patients with intrahepatic cholangiocarcinoma: a surveillance, epidemiology, and end results (SEER) analysis. J Surg Oncol 116(6):643–650. https://​doi.​org/​10.​1002/​jso.​24720 CrossRefPubMed
36.
Zurück zum Zitat Adsay NV, Bagci P, Tajiri T, Oliva I, Ohike N, Balci S, Gonzalez RS, Basturk O, Jang KT, Roa JC (2012) Pathologic staging of pancreatic, ampullary, biliary, and gallbladder cancers: pitfalls and practical limitations of the current AJCC/UICC TNM staging system and opportunities for improvement. Semin Diagn Pathol 29(3):127–141. https://doi.org/10.1053/j.semdp.2012.08.010 CrossRefPubMed Adsay NV, Bagci P, Tajiri T, Oliva I, Ohike N, Balci S, Gonzalez RS, Basturk O, Jang KT, Roa JC (2012) Pathologic staging of pancreatic, ampullary, biliary, and gallbladder cancers: pitfalls and practical limitations of the current AJCC/UICC TNM staging system and opportunities for improvement. Semin Diagn Pathol 29(3):127–141. https://​doi.​org/​10.​1053/​j.​semdp.​2012.​08.​010 CrossRefPubMed
37.
Zurück zum Zitat Balci S, Basturk O, Saka B, Bagci P, Postlewait LM, Tajiri T, Jang KT, Ohike N, Kim GE, Krasinskas A, Choi H, Sarmiento JM, Kooby DA, El-Rayes BF, Knight JH, Goodman M, Akkas G, Reid MD, Maithel SK, Adsay V (2015) Substaging nodal status in ampullary carcinomas has significant prognostic value: proposed revised staging based on an analysis of 313 well-characterized cases. Ann Surg Oncol 22(13):4392–4401. https://doi.org/10.1245/s10434-015-4499-y CrossRefPubMedPubMedCentral Balci S, Basturk O, Saka B, Bagci P, Postlewait LM, Tajiri T, Jang KT, Ohike N, Kim GE, Krasinskas A, Choi H, Sarmiento JM, Kooby DA, El-Rayes BF, Knight JH, Goodman M, Akkas G, Reid MD, Maithel SK, Adsay V (2015) Substaging nodal status in ampullary carcinomas has significant prognostic value: proposed revised staging based on an analysis of 313 well-characterized cases. Ann Surg Oncol 22(13):4392–4401. https://​doi.​org/​10.​1245/​s10434-015-4499-y CrossRefPubMedPubMedCentral
39.
Zurück zum Zitat Saka B, Balci S, Basturk O, Bagci P, Postlewait LM, Maithel S, Knight J, El-Rayes B, Kooby D, Sarmiento J, Muraki T, Oliva I, Bandyopadhyay S, Akkas G, Goodman M, Reid MD, Krasinskas A, Everett R, Adsay V (2016) Pancreatic ductal adenocarcinoma is spread to the peripancreatic soft tissue in the majority of resected cases, rendering the AJCC T-stage protocol (7th edition) inapplicable and insignificant: a size-based staging system (pT1: </=2, pT2: >2-</=4, pT3: >4 cm) is more valid and clinically relevant. Ann Surg Oncol 23(6):2010–2018. https://doi.org/10.1245/s10434-016-5093-7 CrossRefPubMedPubMedCentral Saka B, Balci S, Basturk O, Bagci P, Postlewait LM, Maithel S, Knight J, El-Rayes B, Kooby D, Sarmiento J, Muraki T, Oliva I, Bandyopadhyay S, Akkas G, Goodman M, Reid MD, Krasinskas A, Everett R, Adsay V (2016) Pancreatic ductal adenocarcinoma is spread to the peripancreatic soft tissue in the majority of resected cases, rendering the AJCC T-stage protocol (7th edition) inapplicable and insignificant: a size-based staging system (pT1: </=2, pT2: >2-</=4, pT3: >4 cm) is more valid and clinically relevant. Ann Surg Oncol 23(6):2010–2018. https://​doi.​org/​10.​1245/​s10434-016-5093-7 CrossRefPubMedPubMedCentral
42.
Zurück zum Zitat Allen PJ, Kuk D, Castillo CF, Basturk O, Wolfgang CL, Cameron JL, Lillemoe KD, Ferrone CR, Morales-Oyarvide V, He J, Weiss MJ, Hruban RH, Gonen M, Klimstra DS, Mino-Kenudson M (2017) Multi-institutional validation study of the American joint commission on cancer (8th edition) changes for T and N staging in patients with pancreatic adenocarcinoma. Ann Surg 265(1):185–191. https://doi.org/10.1097/SLA.0000000000001763 CrossRefPubMedPubMedCentral Allen PJ, Kuk D, Castillo CF, Basturk O, Wolfgang CL, Cameron JL, Lillemoe KD, Ferrone CR, Morales-Oyarvide V, He J, Weiss MJ, Hruban RH, Gonen M, Klimstra DS, Mino-Kenudson M (2017) Multi-institutional validation study of the American joint commission on cancer (8th edition) changes for T and N staging in patients with pancreatic adenocarcinoma. Ann Surg 265(1):185–191. https://​doi.​org/​10.​1097/​SLA.​0000000000001763​ CrossRefPubMedPubMedCentral
43.
Zurück zum Zitat Kamarajah SK, Burns WR, Frankel TL, Cho CS, Nathan H (2017) Validation of the American joint commission on cancer (AJCC) 8th edition staging system for patients with pancreatic adenocarcinoma: a surveillance, epidemiology and end results (SEER) analysis. Ann Surg Oncol 24(7):2023–2030. https://doi.org/10.1245/s10434-017-5810-x CrossRefPubMed Kamarajah SK, Burns WR, Frankel TL, Cho CS, Nathan H (2017) Validation of the American joint commission on cancer (AJCC) 8th edition staging system for patients with pancreatic adenocarcinoma: a surveillance, epidemiology and end results (SEER) analysis. Ann Surg Oncol 24(7):2023–2030. https://​doi.​org/​10.​1245/​s10434-017-5810-x CrossRefPubMed
44.
Zurück zum Zitat Rindi G, Kloppel G, Alhman H, Caplin M, Couvelard A, de Herder WW, Erikssson B, Falchetti A, Falconi M, Komminoth P, Korner M, Lopes JM, McNicol AM, Nilsson O, Perren A, Scarpa A, Scoazec JY, Wiedenmann B, all other Frascati Consensus Conference p, European Neuroendocrine Tumor S (2006) TNM staging of foregut (neuro)endocrine tumors: a consensus proposal including a grading system. Virchows Arch 449(4):395–401. https://doi.org/10.1007/s00428-006-0250-1 CrossRefPubMedPubMedCentral Rindi G, Kloppel G, Alhman H, Caplin M, Couvelard A, de Herder WW, Erikssson B, Falchetti A, Falconi M, Komminoth P, Korner M, Lopes JM, McNicol AM, Nilsson O, Perren A, Scarpa A, Scoazec JY, Wiedenmann B, all other Frascati Consensus Conference p, European Neuroendocrine Tumor S (2006) TNM staging of foregut (neuro)endocrine tumors: a consensus proposal including a grading system. Virchows Arch 449(4):395–401. https://​doi.​org/​10.​1007/​s00428-006-0250-1 CrossRefPubMedPubMedCentral
45.
Zurück zum Zitat Rindi G, Falconi M, Klersy C, Albarello L, Boninsegna L, Buchler MW, Capella C, Caplin M, Couvelard A, Doglioni C, Delle Fave G, Fischer L, Fusai G, de Herder WW, Jann H, Komminoth P, de Krijger RR, La Rosa S, Luong TV, Pape U, Perren A, Ruszniewski P, Scarpa A, Schmitt A, Solcia E, Wiedenmann B (2012) TNM staging of neoplasms of the endocrine pancreas: results from a large international cohort study. J Natl Cancer Inst 104(10):764–777. https://doi.org/10.1093/jnci/djs208 CrossRefPubMed Rindi G, Falconi M, Klersy C, Albarello L, Boninsegna L, Buchler MW, Capella C, Caplin M, Couvelard A, Doglioni C, Delle Fave G, Fischer L, Fusai G, de Herder WW, Jann H, Komminoth P, de Krijger RR, La Rosa S, Luong TV, Pape U, Perren A, Ruszniewski P, Scarpa A, Schmitt A, Solcia E, Wiedenmann B (2012) TNM staging of neoplasms of the endocrine pancreas: results from a large international cohort study. J Natl Cancer Inst 104(10):764–777. https://​doi.​org/​10.​1093/​jnci/​djs208 CrossRefPubMed
46.
Zurück zum Zitat Rami-Porta R, Bolejack V, Crowley J, Ball D, Kim J, Lyons G, Rice T, Suzuki K, Thomas CF Jr, Travis WD, Wu YL, Staging I, Prognostic Factors Committee AB, Participating I (2015) The IASLC lung cancer staging project: proposals for the revisions of the T descriptors in the forthcoming eighth edition of the TNM classification for lung cancer. J Thorac Oncol 10(7):990–1003. https://doi.org/10.1097/JTO.0000000000000559 CrossRefPubMed Rami-Porta R, Bolejack V, Crowley J, Ball D, Kim J, Lyons G, Rice T, Suzuki K, Thomas CF Jr, Travis WD, Wu YL, Staging I, Prognostic Factors Committee AB, Participating I (2015) The IASLC lung cancer staging project: proposals for the revisions of the T descriptors in the forthcoming eighth edition of the TNM classification for lung cancer. J Thorac Oncol 10(7):990–1003. https://​doi.​org/​10.​1097/​JTO.​0000000000000559​ CrossRefPubMed
47.
Zurück zum Zitat Eberhardt WE, Mitchell A, Crowley J, Kondo H, Kim YT, Turrisi A 3rd, Goldstraw P, Rami-Porta R, International Association for Study of Lung Cancer S, Prognostic Factors Committee ABM, Participating I (2015) The IASLC lung cancer staging project: proposals for the revision of the M descriptors in the forthcoming eighth edition of the TNM classification of lung cancer. J Thorac Oncol 10(11):1515–1522. https://doi.org/10.1097/JTO.0000000000000673 CrossRefPubMed Eberhardt WE, Mitchell A, Crowley J, Kondo H, Kim YT, Turrisi A 3rd, Goldstraw P, Rami-Porta R, International Association for Study of Lung Cancer S, Prognostic Factors Committee ABM, Participating I (2015) The IASLC lung cancer staging project: proposals for the revision of the M descriptors in the forthcoming eighth edition of the TNM classification of lung cancer. J Thorac Oncol 10(11):1515–1522. https://​doi.​org/​10.​1097/​JTO.​0000000000000673​ CrossRefPubMed
48.
Zurück zum Zitat Nowak AK, Chansky K, Rice DC, Pass HI, Kindler HL, Shemanski L, Bille A, Rintoul RC, Batirel HF, Thomas CF, Friedberg J, Cedres S, de Perrot M, Rusch VW, Staging, Prognostic Factors Committee AB, Participating I (2016) The IASLC mesothelioma staging project: proposals for revisions of the T descriptors in the forthcoming eighth edition of the TNM classification for pleural mesothelioma. J Thorac Oncol 11(12):2089–2099. https://doi.org/10.1016/j.jtho.2016.08.147 CrossRefPubMed Nowak AK, Chansky K, Rice DC, Pass HI, Kindler HL, Shemanski L, Bille A, Rintoul RC, Batirel HF, Thomas CF, Friedberg J, Cedres S, de Perrot M, Rusch VW, Staging, Prognostic Factors Committee AB, Participating I (2016) The IASLC mesothelioma staging project: proposals for revisions of the T descriptors in the forthcoming eighth edition of the TNM classification for pleural mesothelioma. J Thorac Oncol 11(12):2089–2099. https://​doi.​org/​10.​1016/​j.​jtho.​2016.​08.​147 CrossRefPubMed
49.
Zurück zum Zitat Rice D, Chansky K, Nowak A, Pass H, Kindler H, Shemanski L, Opitz I, Call S, Hasegawa S, Kernstine K, Atinkaya C, Rea F, Nafteux P, Rusch VW, Mesothelioma Domain of the IS, Prognostic Factors Committee ab, participating i (2016) The IASLC mesothelioma staging project: proposals for revisions of the N descriptors in the forthcoming eighth edition of the TNM classification for pleural mesothelioma. J Thorac Oncol 11(12):2100–2111. https://doi.org/10.1016/j.jtho.2016.09.121 CrossRefPubMed Rice D, Chansky K, Nowak A, Pass H, Kindler H, Shemanski L, Opitz I, Call S, Hasegawa S, Kernstine K, Atinkaya C, Rea F, Nafteux P, Rusch VW, Mesothelioma Domain of the IS, Prognostic Factors Committee ab, participating i (2016) The IASLC mesothelioma staging project: proposals for revisions of the N descriptors in the forthcoming eighth edition of the TNM classification for pleural mesothelioma. J Thorac Oncol 11(12):2100–2111. https://​doi.​org/​10.​1016/​j.​jtho.​2016.​09.​121 CrossRefPubMed
50.
Zurück zum Zitat Yang L, Wang S, Zhou Y, Lai S, Xiao G, Gazdar A, Xie Y (2017) Evaluation of the 7th and 8th editions of the AJCC/UICC TNM staging systems for lung cancer in a large North American cohort. Oncotarget. 10.18632/oncotarget.18158 Yang L, Wang S, Zhou Y, Lai S, Xiao G, Gazdar A, Xie Y (2017) Evaluation of the 7th and 8th editions of the AJCC/UICC TNM staging systems for lung cancer in a large North American cohort. Oncotarget. 10.​18632/​oncotarget.​18158
51.
Zurück zum Zitat Chansky K, Detterbeck FC, Nicholson AG, Rusch VW, Vallieres E, Groome P, Kennedy C, Krasnik M, Peake M, Shemanski L, Bolejack V, Crowley JJ, Asamura H, Rami-Porta R, Staging I, Prognostic Factors Committee AB, Participating I (2017) The IASLC lung cancer staging project: external validation of the revision of the TNM stage groupings in the eighth edition of the TNM classification of lung cancer. J Thorac Oncol 12(7):1109–1121. https://doi.org/10.1016/j.jtho.2017.04.011 CrossRefPubMed Chansky K, Detterbeck FC, Nicholson AG, Rusch VW, Vallieres E, Groome P, Kennedy C, Krasnik M, Peake M, Shemanski L, Bolejack V, Crowley JJ, Asamura H, Rami-Porta R, Staging I, Prognostic Factors Committee AB, Participating I (2017) The IASLC lung cancer staging project: external validation of the revision of the TNM stage groupings in the eighth edition of the TNM classification of lung cancer. J Thorac Oncol 12(7):1109–1121. https://​doi.​org/​10.​1016/​j.​jtho.​2017.​04.​011 CrossRefPubMed
52.
Zurück zum Zitat Kondo K, Van Schil P, Detterbeck FC, Okumura M, Stratton K, Giroux D, Asamura H, Crowley J, Falkson C, Filosso PL, Giaccone G, Huang J, Kim J, Lucchi M, Marino M, Marom EM, Nicholson AG, Ruffini E, Staging, Prognostic Factors C, Members of the Advisory B, Participating Institutions of the Thymic D (2014) The IASLC/ITMIG Thymic epithelial tumors staging project: proposals for the N and M components for the forthcoming (8th) edition of the TNM classification of malignant tumors. J Thorac Oncol 9(9):S81–S87. https://doi.org/10.1097/JTO.0000000000000291 CrossRefPubMed Kondo K, Van Schil P, Detterbeck FC, Okumura M, Stratton K, Giroux D, Asamura H, Crowley J, Falkson C, Filosso PL, Giaccone G, Huang J, Kim J, Lucchi M, Marino M, Marom EM, Nicholson AG, Ruffini E, Staging, Prognostic Factors C, Members of the Advisory B, Participating Institutions of the Thymic D (2014) The IASLC/ITMIG Thymic epithelial tumors staging project: proposals for the N and M components for the forthcoming (8th) edition of the TNM classification of malignant tumors. J Thorac Oncol 9(9):S81–S87. https://​doi.​org/​10.​1097/​JTO.​0000000000000291​ CrossRefPubMed
53.
Zurück zum Zitat Nicholson AG, Detterbeck FC, Marino M, Kim J, Stratton K, Giroux D, Asamura H, Crowley J, Falkson C, Filosso PL, Giaccone G, Huang J, Kondo K, Lucchi M, Marom EM, Okumura M, Ruffini E, Van Schil P, Staging, Prognostic Factors C, Members of the Advisory B, Participating Institutions of the Thymic D (2014) The IASLC/ITMIG Thymic epithelial tumors staging project: proposals for the T component for the forthcoming (8th) edition of the TNM classification of malignant tumors. J Thorac Oncol 9(9):S73–S80. https://doi.org/10.1097/JTO.0000000000000303 CrossRefPubMed Nicholson AG, Detterbeck FC, Marino M, Kim J, Stratton K, Giroux D, Asamura H, Crowley J, Falkson C, Filosso PL, Giaccone G, Huang J, Kondo K, Lucchi M, Marom EM, Okumura M, Ruffini E, Van Schil P, Staging, Prognostic Factors C, Members of the Advisory B, Participating Institutions of the Thymic D (2014) The IASLC/ITMIG Thymic epithelial tumors staging project: proposals for the T component for the forthcoming (8th) edition of the TNM classification of malignant tumors. J Thorac Oncol 9(9):S73–S80. https://​doi.​org/​10.​1097/​JTO.​0000000000000303​ CrossRefPubMed
70.
Zurück zum Zitat van der Kwast TH, Amin MB, Billis A, Epstein JI, Griffiths D, Humphrey PA, Montironi R, Wheeler TM, Srigley JR, Egevad L, Delahunt B, Group IPC (2011) International Society of Urological Pathology (ISUP) consensus conference on handling and staging of radical prostatectomy specimens. Working group 2: T2 substaging and prostate cancer volume. Mod Pathol 24(1):16–25. https://doi.org/10.1038/modpathol.2010.156 CrossRefPubMed van der Kwast TH, Amin MB, Billis A, Epstein JI, Griffiths D, Humphrey PA, Montironi R, Wheeler TM, Srigley JR, Egevad L, Delahunt B, Group IPC (2011) International Society of Urological Pathology (ISUP) consensus conference on handling and staging of radical prostatectomy specimens. Working group 2: T2 substaging and prostate cancer volume. Mod Pathol 24(1):16–25. https://​doi.​org/​10.​1038/​modpathol.​2010.​156 CrossRefPubMed
72.
Zurück zum Zitat Moch H, Humphrey P, Ulbright T, Reuter V (2016) WHO classification of tumours of the urinary system and male genital organs, 4th edn. International Agency for Research on Cancer, Lyon Moch H, Humphrey P, Ulbright T, Reuter V (2016) WHO classification of tumours of the urinary system and male genital organs, 4th edn. International Agency for Research on Cancer, Lyon
74.
Zurück zum Zitat Trpkov K, Grignon DJ, Bonsib SM, Amin MB, Billis A, Lopez-Beltran A, Samaratunga H, Tamboli P, Delahunt B, Egevad L, Montironi R, Srigley JR, members of the IRTP (2013) Handling and staging of renal cell carcinoma: the International Society of Urological Pathology Consensus (ISUP) conference recommendations. Am J Surg Pathol 37(10):1505–1517. https://doi.org/10.1097/PAS.0b013e31829a85d0 CrossRefPubMed Trpkov K, Grignon DJ, Bonsib SM, Amin MB, Billis A, Lopez-Beltran A, Samaratunga H, Tamboli P, Delahunt B, Egevad L, Montironi R, Srigley JR, members of the IRTP (2013) Handling and staging of renal cell carcinoma: the International Society of Urological Pathology Consensus (ISUP) conference recommendations. Am J Surg Pathol 37(10):1505–1517. https://​doi.​org/​10.​1097/​PAS.​0b013e31829a85d0​ CrossRefPubMed
Metadaten
Titel
Eighth Edition of the UICC Classification of Malignant Tumours: an overview of the changes in the pathological TNM classification criteria—What has changed and why?
verfasst von
Luca Bertero
Federica Massa
Jasna Metovic
Roberto Zanetti
Isabella Castellano
Umberto Ricardi
Mauro Papotti
Paola Cassoni
Publikationsdatum
05.12.2017
Verlag
Springer Berlin Heidelberg
Erschienen in
Virchows Archiv / Ausgabe 4/2018
Print ISSN: 0945-6317
Elektronische ISSN: 1432-2307
DOI
https://doi.org/10.1007/s00428-017-2276-y

Weitere Artikel der Ausgabe 4/2018

Virchows Archiv 4/2018 Zur Ausgabe

Neu im Fachgebiet Pathologie